Durvalumab,Tremelimumab
astrazeneca
[]
"the rowan study: safety and efficacy of transarterial radioembolization with y-90 glass microspheres and the stride regimen in hepatocellular carcinoma, trial-in-progress." is sharing this exciting abstract at #gi23. 
Fighting a Smarter War on Cancer at the Otto J. Ruesch Center for the Cure of Gastrointestinal Cancers at Georgetown Lombardi Comprehensive Cancer Center.